Biallelic p.R2223H Mutation in the Thyroglobulin Gene Causes Thyroglobulin Retention and Severe Hypothyroidism with Subsequent Development of Thyroid Carcinoma
Authors:
Open Access
- 1 March 2010
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (3) , 1000-1006
Abstract
Context: Dyshormonogenesis due to genetic defect in thyroglobulin (Tg) synthesis and secretion can lead to congenital hypothyroidism. Objectives: The aim of the study was to analyze the TG gene for the presence of mutations and to study the underlying mechanisms leading to dyshormonogenesis. Cases: Two siblings aged 25 and 31 yr presented with recurrent goitrous hypothyroidism with undetectable serum Tg. The older sibling was diagnosed with follicular variant of papillary thyroid carcinoma (FVPTC) at age 21 and metastatic FVPTC 8 yr later. Methods: The entire coding region of TG gene was sequenced. BRAF, RAS, and P53 mutations or PAX8/PPAR-γ rearrangement were screened in the FVPTC. Tg expression was studied by immunohistochemistry. Results: Biallelic c.6725G>A (p.R2223H) and c.6396C>T (p.S2113L) sequence variations were detected in both patients and monoallelic variations in their family members. The c.6396C>T (p.S2113L) sequence variation was found in 14% of 100 population controls, whereas c.6725G>A variation was not present in the controls. Two previously reported polymorphisms (c.2200T>G and c.3082A>G) were present in all the family members. Strong cytoplasmic immunostaining of Tg was observed in the hyperplastic thyroid epithelial cells and weak or no staining in the follicular lumen. Cytoplasmic staining was localized in the endoplasmic reticulum. Reduced staining was found in the FVPTC. Neither RAS, BRAF, or P53 gene mutation nor a PAX8/PPAR-γ rearrangement was detected in the tumor tissue. Conclusions: Biallelic c.6725G>A (p.R2223H) mutation causes Tg retention in the endoplasmic reticulum, resulting in dyshormonogenesis. Prolonged TSH stimulation may promote malignant transformation and development of thyroid cancer. The c.6396C>T (p.S2113L) is a novel polymorphism.Keywords
This publication has 29 references indexed in Scilit:
- The association between serum TSH concentration and thyroid cancerEndocrine-Related Cancer, 2009
- Aberrant BRAF splicing as an alternative mechanism for oncogenic B‐Raf activation in thyroid carcinomaThe Journal of Pathology, 2008
- Mutations in the Iodotyrosine Deiodinase Gene and HypothyroidismNew England Journal of Medicine, 2008
- Biallelic Inactivation of the Dual Oxidase Maturation Factor 2 (DUOXA2) Gene as a Novel Cause of Congenital HypothyroidismThe Journal of Clinical Endocrinology & Metabolism, 2008
- Thyroid-Stimulating Hormone–Initiated Proliferative Signals Converge In vivo on the mTOR Kinase without Activating AKTCancer Research, 2007
- High Incidence of Thyroid Cancer in Long-Standing Goiters with Thyroglobulin MutationsThyroid®, 2005
- Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital HypothyroidismNew England Journal of Medicine, 2002
- Aggressive Metastatic Follicular Thyroid Carcinoma with Anaplastic Transformation Arising from a Long-Standing Goiter in a Patient with Pendred's SyndromeThyroid®, 2001
- Up to date with human thyroglobulinJournal of Endocrinology, 2001
- Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site.Journal of Clinical Investigation, 1998